PortfoliosLab logoPortfoliosLab logo
ISIN
US4333131039
IPO Date
May 22, 2025

Highlights

Market Cap
$5.80B
Enterprise Value
$5.62B
EPS (TTM)
-$6.30
Total Revenue (TTM)
$646.34M
Gross Profit (TTM)
$522.22M
EBITDA (TTM)
-$514.46M
Year Range
$30.08 - $71.44
Target Price
$56.88
ROA (TTM)
-70.02%
ROE (TTM)
-456.88%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

HNGE Performance Chart

Hinge Health, Inc (HNGE) is up 51.5% since the beginning of the year. At $70 per share, HNGE is trading just below its 52-week high of $71.


Loading charts...

S&P 500 Index

Returns By Period

Hinge Health, Inc (HNGE) has returned 51.52% so far this year and 61.09% over the past 12 months.


Hinge Health, Inc

1D
2.22%
1M
27.38%
YTD
51.52%
6M
44.34%
1Y
61.09%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-1.44%
1M
-1.45%
YTD
7.60%
6M
6.59%
1Y
22.24%
3Y*
19.20%
5Y*
11.54%
10Y*
13.71%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HNGE Monthly Returns History

Based on dividend-adjusted daily data since May 22, 2025, HNGE's average daily return is +0.29%, while the average monthly return is +5.77%. At this rate, an investment would double in approximately 1.0 years.

Historically, 50% of months were positive and 50% were negative. The best month was Jun 2025 with a return of +33.2%, while the worst month was Jan 2026 at -24.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 3 months.

On a daily basis, HNGE closed higher 52% of trading days. The best single day was Aug 6, 2025 with a return of +25.6%, while the worst single day was Nov 5, 2025 at -15.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-24.87%22.52%-9.82%15.66%26.03%25.21%51.52%
2025-1.04%33.24%-13.14%24.76%-12.48%1.39%-1.71%-5.03%18.34%

Benchmark Metrics

Hinge Health, Inc has an annualized alpha of 55.97%, beta of 1.32, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since May 22, 2025.

  • This stock captured 96.09% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -534.63%) - a profile typical of hedging or uncorrelated assets.
  • R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
55.97%
Beta
1.32
0.07
Upside Capture
96.09%
Downside Capture
-534.63%

Return for Risk

Risk / Return Rank

HNGE ranks 70 for risk / return — better than 70% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HNGE Risk / Return Rank: 7070
Overall Rank
HNGE Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
HNGE Sortino Ratio Rank: 7272
Sortino Ratio Rank
HNGE Omega Ratio Rank: 7171
Omega Ratio Rank
HNGE Calmar Ratio Rank: 6767
Calmar Ratio Rank
HNGE Martin Ratio Rank: 6767
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Hinge Health, Inc (HNGE) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HNGEBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-0.82

Sortino ratioReturn per unit of downside risk

-0.70

Omega ratioGain probability vs. loss probability

1.22

1.32

-0.10

Calmar ratioReturn relative to maximum drawdown

1.27

2.46

-1.19

Martin ratioReturn relative to average drawdown

2.78

10.92

-8.14

Dividends

Dividend History


Hinge Health, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Hinge Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Hinge Health, Inc was 48.52%, occurring on Feb 6, 2026. Recovery took 78 trading sessions.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-48.52%Feb 2026
6mo 3d3mo 25d
9mo 28dAug 2025 - Jun 2026
2025 selloff2025
-17.28%Jun 2025
16d10d
26dMay 2025 - Jun 2025
2025 correction2025
-16.77%Jul 2025
6d1mo
1mo 6dJul 2025 - Aug 2025
2025 selloff2025
-5.09%Jun 2025
0s5d
5dJun 2025 - Jun 2025
2025 selloff2025
-4.31%May 2025
0s1d
1dMay 2025 - May 2025

Drawdown Indicators


HNGEBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-48.52%

-56.78%

+8.26%

Max Drawdown (1Y)

Largest decline over 1 year

-48.52%

-9.10%

-39.42%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

0.00%

-3.21%

+3.21%

Average Drawdown

Average peak-to-trough decline

-17.81%

-10.71%

-7.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.05%

2.04%

+20.01%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Hinge Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Hinge Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HNGE relative to other companies in the Health Information Services industry. Currently, HNGE has a P/S ratio of 8.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HNGE

Add Hinge Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HNGE